Clinical Trials on Severe Asthma in Russian Federation

Total 204 results

Interregional Public Organization, Russian Respiratory...
AstraZeneca Pharmaceuticals" LLC; Limited Liability Company Regional United...

Unknown

Russian Severe Asthma Registry (RSAR)

Severe Asthma

Russian Federation
AstraZeneca

Completed

Real World Evidence of Benralizumab in Eosinophilic Severe AsThma in Russia (BEST)

Severe Eosinophilic Asthma

Russian Federation
Gamaleya Research Institute of Epidemiology and...

Completed

Open Study of the Duration of Immunity After Vaccination With GamEvac-Combi

Ebola Hemorrhagic Fever

Russian Federation
Gamaleya Research Institute of Epidemiology and...

Completed

Open Study of the Duration of Immunity After Vaccination With GamEvac

Hemorrhagic Fever, Ebola

Russian Federation
PHARMENTERPRISES LLC

Completed

XC8 Safety, Tolerability and Pharmacokinetics in Healthy Volunteers

Asthma

Russian Federation
Petrovsky National Research Centre of Surgery

Recruiting

Efficacy and Safety of Hemoperfusion With Polymyxin B in Septic Shock Associated With Severe Endotoxemia in Cardiac Surgery Patients (РМХ vs SS) (РМХ vs SS)

Multiple Organ Dysfunction With Severe Endotoxemia

Russian Federation
Gamaleya Research Institute of Epidemiology and...

Unknown

An Open Study of the Safety and Pharmacokinetics of a Drug for the Emergency Prevention of Ebola Virus Disease

Ebola Virus Disease

Russian Federation
Biocad

Completed

An International Multicenter, Randomized, Double-blind, Placebo-Controlled Clinical Study of Efficacy and Safety of Two Dosing Regimens of BCD-085 (JSC BIOCAD, Russia) in Patients With Moderate to Severe Plaque Psoriasis (BCD-085-7)

Moderate to Severe Plaque Psoriasis

Russian Federation
Gamaleya Research Institute of Epidemiology and...
CREMS (Centre de Recherche Epidémiologie, Microbiologie et Soins médicaux )

Completed

International Multicenter Study of the Immunogenicity of Medicinal Product GamEvac-Combi

Ebola Virus Disease | Prevention

Russian Federation, Guinea
Federal Research Institute of Pediatric Hematology...

Not yet recruiting

Total Lymphoid Irradiation Pre-HSCT in Severe Congenital Neutropenia

Severe Congenital Neutropenia | GATA2 Deficiency

Russian Federation
Northern State Medical University

Completed

The Effect pf Goal-directed De-escalation in ARDS on Organ Function and Mortality

ARDS, Human | Sepsis, Severe

Russian Federation
I.M. Sechenov First Moscow State Medical University

Completed

Prognosis and Course of COVID-19 Infection in Hospitalised Patients

Covid19 | SARS-CoV Infection

Russian Federation
AbbVie (prior sponsor, Abbott)

Completed

An Open-Label, Prospective Study to Assess the Safety and Effectiveness of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in the Russian Federation

Moderate to Severe Plaque Psoriasis

Russian Federation
I.M. Sechenov First Moscow State Medical University

Enrolling by invitation

Breath Analysis and Arterial Stiffness in Patients With Respiratory Diseases

Cystic Fibrosis | Lymphangioleiomyomatosis | COPD | Bronchial Asthma | Hypersensitivity Pneumonitis | Interstitial Lung Diseases | Chronic Respiratory Diseases

Russian Federation
Chemlmmune Therapeutics LLC
EURRUS Biotech GmbH

Completed

XC8 in the Treatment of Patients With the Eosinophilic Phenotype of Bronchial Asthma

Eosinophilic Asthma | Bronchial Asthma

Russian Federation
Ryazan State Medical University

Recruiting

The Clinical Value of the Nitric Oxide System Components in Asthma and COPD (ASCONO)

Asthma | COPD

Russian Federation
PHARMENTERPRISES LLC
EURRUS Biotech GmbH

Completed

XC8 in the Treatment of Patients With Bronchial Asthma

Bronchial Asthma

Russian Federation
AstraZeneca

Recruiting

A Study to Investigate the Effects of PT027 (Budesonide/Albuterol Sulfate) Metered-dose Inhaler Compared With Placebo on Exercise-Induced Bronchoconstriction in Adult Patients With Asthma (BREATH)

Asthma, Exercise-Induced

Russian Federation
Octapharma

Completed

Pharmacokinetics, Efficacy, Safety, and Immunogenicity of Wilate in Previously Treated Paediatric Patients With Severe Haemophilia A

Severe Hemophilia A

Russian Federation, Ukraine
Northern State Medical University

Completed

The Effect of Closed Suction System on the Incidence of Ventilator-associated Pneumonia. (CSS-VAP)

Encephalitis | Seizures | Pancreatic Diseases | Trauma Injury | Severe Traumatic Brain Injury | Abdominal Sepsis

Russian Federation
Novartis

Completed

Efficacy and Safety of the Combination of Aliskiren (300 mg) and Amlodipine (10 mg) Compared to Amlodipine (10 mg) Monotherapy in Patients With Moderate to Severe Hypertension

Moderate to Severe Hypertension

Russian Federation, Romania, Singapore, Spain, Germany, Philippines
Novartis Pharmaceuticals

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of QAX576 in Asthma Patients

Asthma

Russian Federation, United Kingdom
Oxagen Ltd

Completed

Safety and Efficacy Study of OC000459 Dosed Twice Daily for 28 Days in Asthmatic Subjects

Asthma

Russian Federation
Oxagen Ltd

Completed

OC000459 Dose Finding Study in Patients With Mild to Moderate Persistent Asthma

Mild to Moderate Persistent Asthma

Bulgaria, Russian Federation, Hungary, Romania, Ukraine, Poland
I.M. Sechenov First Moscow State Medical University

Completed

Direct and Cross Effects of Adaptation to Systemic Hyperthermia: Impact on Quality of Life, Neurohormonal and Psychophysiological Human Status

Quality of Life | Metabolic Disturbance | Exercise Tolerance | Hypoxia, Altitude

Russian Federation
Saint Petersburg State University, Russia

Not yet recruiting

Influence of Lung Ultrasonography on the Prognosis and Postoperative Outcomes in Cardiac Surgical Patients

Ischemic Heart Disease | Mitral Insufficiency | Aortic Stenosis, Severe | Mitral Stenosis | Aortic Insufficiency | Ascending Aortic Aneurysm | Mitral Stenosis With Insufficiency | Tricuspid Insufficiency

Russian Federation
Meshalkin Research Institute of Pathology of Circulation

Completed

Surgical Prevention of Atrial Fibrillation in Patients With Rheumatic Mitral Valve Lesion and Left Atrium Enlargement

Atrial Fibrillation | Rheumatic Heart Disease

Russian Federation
R-Pharm International, LLC
Atlant Clinical LLC; Center for Pharmaceutical Analytics LLC; Unimed Laboratories... and other collaborators

Recruiting

Safety and Efficacy of RPH-104 Used to Prevent Recurrent Fever Attacks in Adult Patients With Colchicine Resistant or Colchicine Intolerant Familial Mediterranean Fever

Familial Mediterranean Fever | FMF

Armenia, Georgia, Russian Federation
National Medical Research Center for Therapy and...
Center for Strategic Planning and Management of Biomedical Health Risks of...

Completed

Gut Microbiota in Chronic Noncommunicable Diseases

Diabetes Mellitus, Type 2 | Asthma | Nonalcoholic Fatty Liver Disease | Arterial Hypertension | Heart Failure With Reduced Ejection Fraction | Heart Failure With Preserved Ejection Fraction | Obstructive Pulmonary Disease | Atherosclerosis Occlusive Disease

Russian Federation
Mikhael Petrovich Kostinov
Pfizer

Completed

Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology

Chronic Obstructive Pulmonary Disease | Pneumococcal Infections | Asthma

Russian Federation
Federal State Budgetary Organization, Federal Center...

Completed

AESCULAP® Plasmafit® Cementless Acetabular System With Vitelene® Vitamin E Stabilized Highly Crosslinked Polyethylene

Osteoarthritis, Hip | Degenerative Osteoarthritis | Rheumatic Arthritis

Russian Federation
Eurasian Association of Therapists

Completed

Analysis of Health Status of Сomorbid Adult Patients With COVID-19 Hospitalised in Fourth Wave of SARS-CoV-2 Infection (ACTIV4)

Myocardial Infarction | Stroke | COVID-19 | Diabetes Mellitus | Chronic Kidney Diseases | Ischemic Stroke | Anemia | Atrial Fibrillation | Asthma | Myocarditis | Ischemic Heart Disease | Chronic Heart Failure | Copd | Overweight and Obesity | Pulmonary Embolism | Oncology | Arrythmia | DVT | Hypertensive Heart Disease

Russian Federation
Bayer

Completed

Placebo and Active Controlled Study to Compare the Antipyretic Efficacy of Aspirin® in Patients With Acute Febrile Upper Respiratory Tract Infections Suspected to be of Viral Origin

Respiratory Tract Infections | Fever

Ukraine, Russian Federation
R-Pharm International, LLC
R-Pharm; Atlant Clinical LLC; Unimed Laboratories CJSC; Data Management 365; Center...

Recruiting

Efficacy and Safety of RPH-104 for Resolution and Prevention of Recurring Attacks in Adult Subjects With Familial Mediterranean Fever With Resistance to or Intolerance of Colchicine

Familial Mediterranean Fever | FMF

Armenia, Georgia, Russian Federation
Novartis Pharmaceuticals

Recruiting

Secukinumab Drug Survival, Effectiveness and Tolerability in Pediatric Patients With Psoriasis (SPARROW)

Moderate-to-severe Plaque Psoriasis

Russian Federation
Chiesi Farmaceutici S.p.A.

Completed

Efficacy and Tolerability of Beclomethasone Plus Salbutamol in HFA pMDI Fixed Combination vs Beclomethasone Plus Salbutamol in CFC pMDI Fixed Combination in a 12-week Treatment Period of Adult Patients With Uncontrolled Asthma

Bronchial Asthma

Spain, Italy, Russian Federation, Ukraine
R-Pharm International, LLC
Data Management 365; K-Research, LLC

Completed

Study of the Efficacy and Safety of a Single Administration of Olokizumab and RPH-104 With Standard Therapy in Patients With Severe Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19)

COVID-19

Russian Federation
Cytos Biotechnology AG

Terminated

CYT003-QbG10, a TLR9-agonist, for Treatment of Uncontrolled Moderate to Severe Allergic Asthma

Moderate to Severe Allergic Asthma

United States, Czech Republic, Germany, Hungary, Israel, Poland, Russian Federation, Ukraine
Chiesi Farmaceutici S.p.A.

Completed

Phase II Study to Evaluate the Cardiac Safety of 2 Doses of CHF5993 Both Combined With CHF1535 BID Versus CHF1535 BID in Patients With Moderate to Severe COPD (CARSAF)

Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Bulgaria, Germany, Hungary, Poland, Russian Federation, United Kingdom
Octapharma

Completed

Clinical Study to Investigate the PK, Efficacy, and Safety of Wilate in Patients With Severe Hemophilia A

Severe Hemophilia A

Bulgaria, Poland, Hungary, Romania, Russian Federation
Novartis Pharmaceuticals

Terminated

Efficacy, Safety and Pharmacokinetics of QAV680 Versus Placebo in Patients With Asthma

Asthma

Germany, Russian Federation, United States
AstraZeneca

Completed

Evaluation of Safety and Efficacy of Symbicort® pMDI, With or Without Spacer, in Children (6-11 Years) With Asthma (Spacer)

Asthma

Russian Federation, Hungary, Poland
AstraZeneca

Completed

Asthma in Children

Asthma

Russian Federation
Abbott
Datamap; Linical Co., Ltd.

Completed

A Study Investigating the Immunologic Effects and Safety of 60-day Treatment of the ALK HDM Tablets in Adult Subjects With HDM-Induced Allergic Rhinitis and/or Atopic Asthma

Asthma | Allergy | Rhinitis

Belarus, Russian Federation
AstraZeneca

Completed

Efficacy and Safety of Ciclesonide (CIC) Administered Twice Daily in Pediatric Patients With Asthma.

Asthma

Russian Federation, Hungary, South Africa, Mexico, United States, Poland
AstraZeneca

Completed

Non-interventional Retrospective Multicenter Study of Patients With Bronchial Asthma During a Routine Visit to Out of Patients' Clinics (NIKA)

Asthma

Russian Federation
Astellas Pharma Inc
Astellas Pharma Europe B.V.

Completed

Inhaled Tacrolimus, Add-on to Inhaled Corticosteroids & Long Acting B2 Agonists in Moderate to Severe Persistent Asthma

Asthma, Bronchial | Bronchial Asthma

Russian Federation, Poland, Germany, Ukraine, Czech Republic
Sanofi

Completed

Efficacy and Safety of Fexofenadine in Mild to Moderate Persistent Asthma

Asthma

Poland, Russian Federation, Mexico, Hungary, Guatemala, United States, Costa Rica
Sanofi

Completed

Efficacy and Safety of Fexofenadine in Mild to Moderate Persistent Asthma

Asthma

Russian Federation, Mexico, Hungary, Poland, Guatemala, United States, Costa Rica
AO GENERIUM

Completed

An Efficacy and Safety Study of Genolar® and Xolar® in the Persistent Atopic Bronchial Asthma (NAP)

Bronchial Asthma

Russian Federation

Clinical Trials on Severe Asthma in Russian Federation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Sweden

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations